Technology Platform

Technologies and Intellectual Property

Lotus Biopharma has established a cutting edge microsphere drug delivery system, which enables a wide range of compounds--including proteins, peptides, and small molecules--to be formulated into our innovative controlled long acting injectable products. These microsphere products have a 95 ± 2% drug encapsulation efficiency and zero-order release, with R² of 0.997, of active agents over a predetermined period (e.g., weeks, months). 

Our novel microsphere drug delivery system technology has been patented.